Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Personalized therapy for aggressive brain cancer shows potential

Personalized therapy for aggressive brain cancer shows potential

Researchers engineer 'antibody-like' T cell receptors to combat deadly virus

Researchers engineer 'antibody-like' T cell receptors to combat deadly virus

New optimization method rapidly analyzes nanomedicines for cancer treatment

New optimization method rapidly analyzes nanomedicines for cancer treatment

Researchers report progress in the treatment of aggressive brain tumors

Researchers report progress in the treatment of aggressive brain tumors

Columbia researchers unravel why some glioblastomas respond to immunotherapy

Columbia researchers unravel why some glioblastomas respond to immunotherapy

Immunotherapy drug can be effective in treating patients with recurrent brain tumors

Immunotherapy drug can be effective in treating patients with recurrent brain tumors

Scientists create 3D-bioprinted brain model to study interaction with immune cells

Scientists create 3D-bioprinted brain model to study interaction with immune cells

New breakthrough study can impact drug development and personalized medicine

New breakthrough study can impact drug development and personalized medicine

CIRM announces funding for UCI researchers to develop new treatment for Huntington’s disease

CIRM announces funding for UCI researchers to develop new treatment for Huntington’s disease

Study reveals how glioblastomas resist the effects of antiangiogenic drugs

Study reveals how glioblastomas resist the effects of antiangiogenic drugs

Corning Life Sciences to highlight advanced 3D cell culture technologies and tools at SLAS 2019

Corning Life Sciences to highlight advanced 3D cell culture technologies and tools at SLAS 2019

Researchers discover immune regulator that appears to dictate glioblastoma

Researchers discover immune regulator that appears to dictate glioblastoma

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

MGH-led research team reveals how solid stress impacts tissue surrounding brain tumors

MGH-led research team reveals how solid stress impacts tissue surrounding brain tumors

Molecular signatures reveal why women are more likely to die from glioblastoma

Molecular signatures reveal why women are more likely to die from glioblastoma

Getting the Most Out of the CLARITY Technique

Getting the Most Out of the CLARITY Technique

The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors

The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors

Scientists find answers to how cancer spreads

Scientists find answers to how cancer spreads

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

UA researchers discover promising lead in genetic approach to treating deadly brain cancer